Teva Pharmaceutical Industries Limited (TEVA)
Q1 2012 Earnings Call
May 09, 2012 8:30 am ET
ExecutivesKevin Mannix - Director of Investor Relations - Teva North America Shlomo Yanai - Chief Executive Officer and President Eyal Desheh - Chief Financial Officer Jeremy Levin - William S. Marth - Chief Executive Officer of Teva Americas and President of Teva Americas Robert Koremans - Michael Hayden - Unknown Executive - Gerard W.M. Van Odijk - Former Chief Executive Officer of Teva Europe and President of Teva Europe Analysts Christopher Schott - JP Morgan Chase & Co, Research Division Aaron Gal - Sanford C. Bernstein & Co., LLC., Research Division Traver A. Davis - Piper Jaffray Companies, Research Division Corey B. Davis - Jefferies & Company, Inc., Research Division David G. Buck - The Buckingham Research Group Incorporated Gregory B. Gilbert - BofA Merrill Lynch, Research Division Limor Gruber - Psagot Investment House Ltd., Research Division Frank H. Pinkerton - SunTrust Robinson Humphrey, Inc., Research Division Elliot Wilbur - Needham & Company, LLC, Research Division Douglas D. Tsao - Barclays Capital, Research Division Marc Goodman - UBS Investment Bank, Research Division Florent Cespedes - Exane BNP Paribas, Research Division Jason M. Gerberry - Leerink Swann LLC, Research Division Shibani Malhotra - RBC Capital Markets, LLC, Research Division Presentation Operator
Previous Statements by TEVA
» Teva's CEO Presents at Barclays Capital Global Healthcare Conference (Transcript)
» Teva Pharmaceutical Industries' Management Presents at Citi Global Health Care Conference (Transcript)
» Teva Pharmaceutical's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV